GE HealthCare Technologies Inc. (NASDAQ:GEHC - Get Free Report)'s stock price gapped down before the market opened on Tuesday . The stock had previously closed at $88.94, but opened at $81.04. GE HealthCare Technologies shares last traded at $80.07, with a volume of 3,435,764 shares traded.
Wall Street Analyst Weigh In
A number of brokerages recently weighed in on GEHC. Argus increased their price target on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a "buy" rating in a research note on Monday, April 1st. Mizuho increased their price objective on GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a "buy" rating in a report on Thursday, April 11th. Citigroup lifted their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a "buy" rating in a report on Wednesday, April 3rd. Morgan Stanley boosted their price target on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an "equal weight" rating in a research report on Monday, February 12th. Finally, HSBC initiated coverage on GE HealthCare Technologies in a research report on Thursday, February 15th. They issued a "buy" rating and a $100.00 target price on the stock. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $95.09.
View Our Latest Research Report on GE HealthCare Technologies
GE HealthCare Technologies Stock Down 14.3 %
The stock's fifty day moving average is $88.98 and its 200 day moving average is $78.75. The company has a market capitalization of $34.79 billion, a P/E ratio of 26.79, a price-to-earnings-growth ratio of 3.00 and a beta of 0.95. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The business had revenue of $5.20 billion during the quarter, compared to analyst estimates of $5.09 billion. During the same period last year, the business posted $1.31 earnings per share. GE HealthCare Technologies's quarterly revenue was up 5.3% compared to the same quarter last year. Research analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.
GE HealthCare Technologies Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.16%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies's dividend payout ratio is currently 3.97%.
Institutional Investors Weigh In On GE HealthCare Technologies
Several hedge funds have recently bought and sold shares of GEHC. Vanguard Group Inc. lifted its stake in shares of GE HealthCare Technologies by 14.7% in the third quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company's stock worth $3,029,917,000 after buying an additional 5,693,244 shares in the last quarter. Norges Bank bought a new position in shares of GE HealthCare Technologies during the fourth quarter valued at $229,052,000. Capital Research Global Investors raised its position in GE HealthCare Technologies by 2.8% in the 4th quarter. Capital Research Global Investors now owns 51,344,719 shares of the company's stock worth $3,969,975,000 after buying an additional 1,401,566 shares during the last quarter. Ameriprise Financial Inc. raised its position in GE HealthCare Technologies by 84.4% in the 3rd quarter. Ameriprise Financial Inc. now owns 2,668,695 shares of the company's stock worth $181,578,000 after buying an additional 1,221,436 shares during the last quarter. Finally, Perpetual Ltd bought a new position in GE HealthCare Technologies during the 1st quarter valued at about $96,135,000. Institutional investors own 82.06% of the company's stock.
About GE HealthCare Technologies
(
Get Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Further Reading
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
